BioSpace News Archive

Genetown

Pear Therapeutics to Present at Canaccord Genuity 38th Annual Growth Conference

Pear Therapeutics, Inc. will present at the Canaccord Genuity 38th Annual Growth Conference on Thursday, August 9th at 10:30 a.m. at the InterContinental Boston.

July 31, 2018
·
1 min read
Drug Development

GE Healthcare and Lantheus Announce Start of a Phase 3 Clinical Trial of Flurpiridaz, an Investigational Agent Being Evaluated for the Detection of Coronary Artery Disease

GE Healthcare and Lantheus Holdings, Inc. (NASDAQ: LNTH), have started a second Phase 3 clinical trial of Flurpiridaz.

July 31, 2018
·
6 min read
Genetown

Infraredx Announces Launch of Makoto™ Intravascular Imaging System and Dualpro™ IVUS+NIRS Catheter in Japan

Nipro Vascular Company Brings the First Dual-Modality Intravascular Imaging System and Catheter to the World’s Largest Imaging Market.

July 31, 2018
·
4 min read
Drug Development

180 Therapeutics Announces Positive Results from a Phase 2a Clinical Trial of Anti-TNF Therapy in Dupuytren’s Disease

Potential New Treatment Option for a Severe and Disabling Inflammatory Hand Disease

July 31, 2018
·
4 min read
Lone Star Bio

Pharm-Olam International Supports Clinical Trials and Sponsors Compliance with GDPR

Pharm-Olam International provides multiple resources for life science organizations to comply with the new European Union General Data Protection Regulation (GDPR).

July 31, 2018
·
2 min read
Drug Development

Kala Pharmaceuticals Announces Dosing of First Patient in Phase 3 STRIDE 3 Trial of KPI-121 0.25% in Patients with Dry Eye Disease

Phase 3 trial of KPI-121 0.25% for the short-term treatment of dry eye disease.

July 31, 2018
·
8 min read
Business

Generation Bio Appoints Charles Rowland to its Board of Directors

Generation Bio is a company developing the first genetic medicines that can be titrated to effect and re-dosed for a lifetime of benefit.

July 31, 2018
·
2 min read
Business

Second Sight to Discuss Second Quarter 2018 Financial Results on August 7, 2018 Conference Call

Second Sight Medical Products, Inc. will release its 2018 second quarter financial results on Tuesday, August 7, 2018, after the close of the U.S. financial markets.

July 31, 2018
·
5 min read
Business

CANbridge Life Sciences Appoints Chief Medical Officer

Dr. Orfali replaced Dr. Mark Goldberg, who was acting as interim Chief Medical Officer.

July 31, 2018
·
5 min read
Business

Celsius Holdings, Inc. Names Edwin Negron-Carballo As Chief Financial Officer To Support Continued Growth

Experienced Financial Executive Brings Over 30 Years’ Experience to Celsius

July 31, 2018
·
5 min read